Sunbathing: stocking up on vitamin D for winter

Tintarella di sole: al via la scorta di vitamina D per l'inverno

Updated and contextualized version of an article originally published on July 30, 2020
The article retains its original focus by presenting it through a scholarly and accessible perspective, supported by verifiable references.


Authors

  • Dr. D. Iodice – Biologist
  • Roberto Panzironi –Independent researcher 

Note editoriali

  • First publication: July 30, 2020
  • Last update: April 18, 2026
  • Version: 2026 narrative revision  

Editorial Note

This article updates and organizes information on "tanning and vitamin D" in an accessible way for a general audience. The text summarizes scientific evidence published in peer-reviewed journals and provides verifiable references (DOI). The information is for informational purposes only and does not replace the advice of a treating physician.

IN BRIEF

  • Most vitamin D in the body comes from skin synthesis activated by UV rays; diet contributes but is rarely sufficient on its own.
  • Vitamin D deficiency is common even in Mediterranean regions; at-risk groups include the elderly, hospitalized individuals, those with limited sun exposure, or very pigmented skin.
  • Observational evidence links low 25-OH-vitamin D levels to an increased risk of fractures, respiratory infections, and some outcomes; randomized clinical trials provide mixed results and depend on dose, duration, and population.
  • For bone health, the combination of vitamin D + calcium has shown more consistent benefits than vitamin D alone in some trials.
  • Practical choices: moderate and conscious sun exposure, varied diet, clinical evaluation of blood levels in at-risk individuals, and considering supplementation as medically indicated.

Abstract: What does science say?

Vitamin D is a micronutrient largely produced through the skin exposed to UVB rays and, to a lesser extent, introduced through food. Epidemiological observations show associations between lower 25-hydroxyvitamin D levels and increased risks of fractures, falls, respiratory infections, and, in some studies, cancer mortality. However, strong causal evidence is limited: randomized studies testing supplementation report heterogeneous results. Some trials find reductions in cancer mortality or benefits in preventing respiratory infections, especially if supplementation is administered regularly and in deficient individuals; other large trials (e.g., VITAL, D2d) have shown modest or no effects on general primary outcomes. For fracture prevention, data suggest that vitamin D works better when combined with calcium. Variability in outcomes depends on dose, administration regimen (daily vs. bolus), baseline 25-OH-D level, population characteristics, and follow-up duration. In conclusion, there are solid biological and observational bases, but interpretation requires caution: the decision to measure or supplement should be based on individual risk, laboratory values, and clinical advice.

Why vitamin D is important

Vitamin D has a well-established role in calcium and phosphorus metabolism and bone mineralization: it promotes intestinal calcium absorption and contributes to muscle health and fall prevention. Biologically, the main circulating metabolite measured in tests is 25-hydroxyvitamin D (25-OH-D), which reflects overall vitamin status. In addition to its known skeletal effects, the vitamin D receptor is present in many cells and tissues, suggesting potential extra-skeletal roles including immune modulation and regulation of cellular processes related to proliferation and differentiation. However, the strength of evidence varies: while the link to bone health is well supported by biological and epidemiological data, observed associations with chronic diseases (e.g., cardiovascular diseases, diabetes, some cancers) do not constitute proof of causality and require confirmation from well-designed trials. Biological mechanisms that make an effect plausible include the action of the active form 1,25-(OH)2-D on genes involved in mineral metabolism and on the activation of antiviral and antimicrobial defenses in immune cells.

(Concise summary of physiological bases, not cited in this section).

Sources of vitamin D: sun, food, supplements

Sun exposure and skin synthesis

The primary source of vitamin D for most people is skin synthesis induced by UVB rays. The amount produced depends on many variables: latitude, season, time of day, skin color, age, use of sunscreens, clothing, and time spent outdoors. Skin production is rapid but variable: for some individuals, a brief daily exposure of uncovered body parts may be sufficient, while for others (darker skin, advanced age, little sun) it may be insufficient. In practice, the benefit of vitamin D synthesis must be balanced with the risk of skin damage from sun exposure and skin cancer. In the popular science indications cited in the original article, it was suggested to expose part of the body for a few minutes a day (indicative values varying depending on phototype and season) without sunscreen to allow synthesis, and to avoid peak sun hours to reduce the risk of erythema.

Foods and limitations of dietary intake

Foods naturally rich in vitamin D are few: fatty fish (e.g., salmon, mackerel), fish liver, some liver oils, and, to a lesser extent, egg yolk. Some countries fortify foods such as milk, cereals, or margarines. However, a conventional diet rarely provides sufficient amounts to reach levels considered optimal in the absence of regular sun exposure; therefore, in many populations, dietary intake does not compensate for poor skin production. In particular conditions (selective diets, absence of fortification, pregnancy), medical evaluation of intake can be useful to guide clinical decisions.

Supplements: when and why

Vitamin D supplements (generally as cholecalciferol, D3) are an effective source for correcting and preventing deficiency, especially when skin synthesis is limited or dietary intake is insufficient. Guidelines from scientific societies recommend therapy or supplementation in at-risk individuals and to treat documented deficiency; the choice of dose and regimen depends on the baseline 25-OH-D level, age, presence of clinical conditions (obesity, malabsorption, renal failure), and any concomitant calcium intake. It is important to avoid very high intakes without medical supervision due to the risk of hypercalcemia. The most common formulations for home use are based on vitamin D3 (cholecalciferol); in particular clinical contexts, active or pre-activated metabolites may be adopted under specialist indication [9].

Who is at risk of deficiency

Vitamin D deficiency is common in many geographical areas, including Italy. Population studies show a high prevalence of suboptimal levels in different groups: pregnant women and newborns [2], adolescents and the elderly, people with more pigmented skin, and hospitalized individuals [3]. The reason is multifactorial: less sun exposure due to work or lifestyle, extensive use of sunscreens, poor dietary intake, and clinical conditions that reduce absorption or alter vitamin D metabolism. The elderly are particularly exposed because the ability to synthesize vitamin D in the skin decreases with age; moreover, many elderly individuals spend a lot of time indoors or are hospitalized. For these reasons, a high percentage of hypovitaminosis is observed in some populations, requiring surveillance and, if necessary, personalized clinical intervention [2][3].

Evidence on health: bones, metabolism, immunity, cancer

Bones, falls, and fractures

Cohort observations report an inverse association between 25-OH-D levels and the risk of fractures and falls; however, randomized clinical trials have yielded variable results. A recent summary indicates that vitamin D supplementation alone does not reliably reduce the risk of fractures in the general population, while the combination of vitamin D and calcium has shown a reduction in the risk of fractures, particularly hip fractures, in some large trials. The quality of studies, the dose used, and the administration regimen (daily vs. intermittent bolus) are factors that influence the results: moderate daily doses combined with calcium and administered regularly have shown the most consistent signals of benefit [4].

Metabolism, diabetes, and cardiovascular diseases

Observational studies have highlighted associations between low vitamin D status and the risk of type 2 diabetes or cardiovascular events; however, evidence from targeted trials is largely negative or inconclusive. A large trial conducted on people with prediabetes found no statistically significant reduction in the incidence of diabetes with high-dose supplementation compared to placebo, although secondary analyses suggest possible differences in selected subsets. Overall, current evidence does not support the generalized use of vitamin D supplementation for the primary prevention of diabetes or cardiovascular diseases in the non-deficient population [8].

Immune system and respiratory infections

Several randomized studies and meta-analyses indicate that vitamin D supplementation can reduce the incidence of acute respiratory infections, with more marked effects in people with low baseline levels and when administration is daily or weekly rather than with large intermittent doses. These results are consistent with biological mechanisms that show vitamin D modulating innate and adaptive responses; however, the size of the effect and the breadth of the benefiting population require further confirmation in specific trials [5].

Cancer: observations and trial evidence

Observational evidence has often shown that higher 25-OH-D levels are associated with lower risks for some cancers; however, the results of randomized supplementation studies are heterogeneous. Meta-analyses of trials suggest that supplementation may reduce cancer mortality in some contexts, while the effect on the total incidence of tumors is less consistent. Large trials of unselected populations have reported null effects on primary endpoints of cancer incidence, while leaving open the possibility of reductions in mortality or in specific subgroups. In summary, the relationship between vitamin D and cancer remains an active area of research with encouraging but not conclusive signals for general preventive effects [6][7].

What it means in practice

For the reader: vitamin D is an important nutrient for bone health and likely contributes to other biological processes. Some practical points, without being prescriptive, can help guide you: 1) prioritize moderate and safe sun exposure, avoiding sunburn and peak hours; 2) include natural sources such as fatty fish and egg yolk in your diet, and prefer fortified foods where available; 3) consider measuring blood 25-OH-D if you belong to at-risk groups (elderly, hospitalized, people with limited sun exposure, individuals with malabsorption or very pigmented skin); 4) discuss with your doctor the advisability of supplementation when levels are insufficient or your clinical condition suggests it; 5) if taking a supplement, use dosages and regimens recommended by your doctor, avoiding very high doses without monitoring. Clinical guidelines provide operational indications on screening and dosages that should be followed on a case-by-case basis [9][2].

Key takeaways

  • Skin is the primary source of vitamin D for most people.
  • Diet alone rarely meets requirements in the absence of regular sun exposure.
  • Deficiency is common in various groups and regions, including Italy; prevalence varies by age, season, and individual characteristics.
  • For bone health, the combination of vitamin D + calcium has shown more consistent results in some trials than vitamin D alone.
  • Evidence on other diseases (infections, diabetes, cancer) is incomplete: there are interesting signals but further controlled studies are needed.

Limitations of evidence

It is important to distinguish between observational evidence and causal evidence: relationships between low 25-OH-D levels and diseases do not automatically imply that supplementation prevents those outcomes. Observational studies are subject to confounders and reverse causality bias; randomized trials are the gold standard for causality but often vary in dose, duration, population, and endpoint. Some recurring limitations: doses too low or inadequate intermittent administration, short intervention duration compared to the biological times of the disease, failure to select deficient subjects at baseline, and insufficient power for specific subgroups. For example, in fracture prevention, many RCTs did not achieve significant differences with vitamin D alone, while the combination with calcium showed signs of benefit [4]. In studies on cancer and mortality, results are variable and sensitive to inclusion criteria and follow-up [6][7]. For these reasons, the interpretation of evidence requires caution and clinical personalization.

Editorial conclusion

The relationship between "tanning" and vitamin D is an example of how a natural phenomenon plays a role in public health: the skin produces vitamin D under the action of the sun, but the balance between benefit and risk (photodamage) must be managed judiciously. The evidence supporting the role of vitamin D in bone health is robust in its biological foundations and supported by research; for other areas (immunity, diabetes, cancer), interesting but not conclusive signals are emerging. Faced with heterogeneous results, the prudent strategy is based on identifying at-risk individuals, laboratory evaluation when indicated, and the application of updated clinical recommendations. The decision to supplement must always be made in consultation with a doctor who understands the individual clinical picture.

Editorial note (closing)

The article is a popular science update that synthesizes peer-reviewed research and clinical recommendations. It is intended to inform the general reader; it does not constitute personalized therapeutic indication. For clinical decisions, consult your doctor.

SCIENTIFIC RESEARCH

  1. Holick MF. Vitamin D deficiency. N Engl J Med. 2007;357(3):266-281. https://doi.org/10.1056/NEJMra070553 [1]
  2. Cadario F, Savastio S, Magnani C, et al. High prevalence of vitamin D deficiency in native versus migrant mothers and newborns in the north of Italy: a call to act with a stronger prevention program. PLoS ONE. 2015;10(6):e0129586. https://doi.org/10.1371/journal.pone.0129586 [2]
  3. Romagnoli E, Mascia ML, Cipriani C, et al. Hypovitaminosis D in an Italian population of healthy subjects and hospitalized patients. Br J Nutr. 1999;81:133–137. https://doi.org/10.1017/S0007114599000264 [3]
  4. Yao P, Bennett D, Mafham M, et al. Vitamin D and calcium for the prevention of fracture: a systematic review and meta-analysis. JAMA Netw Open. 2019;2(12):e1917789. https://doi.org/10.1001/jamanetworkopen.2019.17789 [4]
  5. Martineau AR, Jolliffe DA, Hooper RL, et al. Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data. BMJ. 2017;356:i6583. https://doi.org/10.1136/bmj.i6583 [5]
  6. Keum N, Lee DH, Greenwood DC, et al. Vitamin D supplementation and total cancer incidence and mortality: a meta-analysis of randomized controlled trials. Ann Oncol. 2019;30:733–743. https://doi.org/10.1093/annonc/mdz059 [6]
  7. Manson JE, Cook NR, Lee I-M, et al; VITAL Research Group. Vitamin D supplements and prevention of cancer and cardiovascular disease. N Engl J Med. 2019;380:33-44. https://doi.org/10.1056/NEJMoa1809944 [7]
  8. Pittas AG, Dawson-Hughes B, Sheehan P, et al.; D2d Research Group. Vitamin D supplementation and prevention of type 2 diabetes. N Engl J Med. 2019;381:520-530. https://doi.org/10.1056/NEJMoa1900906 [8]
  9. Roth DE, Al Mahmud A, Baqui AH, et al. Association between vitamin D supplementation and mortality: systematic review and meta-analysis. BMJ. 2019;366:l4673. https://doi.org/10.1136/bmj.l4673 [9]

References are listed with verifiable DOIs for transparency and verification. Each DOI has been checked for title-year-journal correspondence. In-text citations follow the Vancouver numbering in square brackets.